IRIS
BARRECA, Maria Letizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.012
EU - Europa 2.315
AS - Asia 1.369
SA - Sud America 477
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 11.214
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.940
RU - Federazione Russa 811
SG - Singapore 540
BR - Brasile 428
CN - Cina 402
IE - Irlanda 374
SE - Svezia 329
UA - Ucraina 283
HK - Hong Kong 169
DE - Germania 165
VN - Vietnam 146
GB - Regno Unito 120
FI - Finlandia 82
IT - Italia 46
CA - Canada 40
IN - India 32
AR - Argentina 22
MX - Messico 21
CZ - Repubblica Ceca 18
PL - Polonia 16
TR - Turchia 15
BE - Belgio 14
IQ - Iraq 11
BD - Bangladesh 10
FR - Francia 10
ZA - Sudafrica 10
NL - Olanda 8
UZ - Uzbekistan 8
EC - Ecuador 7
EG - Egitto 6
ES - Italia 6
IR - Iran 6
TN - Tunisia 6
MA - Marocco 5
UY - Uruguay 5
VE - Venezuela 5
AT - Austria 4
CI - Costa d'Avorio 4
CO - Colombia 4
HN - Honduras 4
LT - Lituania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
CL - Cile 3
GR - Grecia 3
GT - Guatemala 3
ID - Indonesia 3
IL - Israele 3
JP - Giappone 3
PE - Perù 3
CY - Cipro 2
KE - Kenya 2
KG - Kirghizistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.214
Salva come PNG Salva come JPEG
Città #
Dallas 4.542
Jacksonville 487
Moscow 411
Dublin 374
Chandler 364
Singapore 304
Ashburn 230
Nyköping 224
Beijing 172
Hong Kong 169
Dong Ket 115
Los Angeles 89
Princeton 75
Cambridge 73
Medford 71
Des Moines 58
Boardman 50
The Dalles 46
Dearborn 41
Buffalo 38
Council Bluffs 30
Lancaster 28
São Paulo 28
Ann Arbor 27
Woodbridge 27
Wilmington 19
Brno 18
Nanjing 18
Tianjin 18
Jinan 16
Rio de Janeiro 16
Belo Horizonte 15
Haikou 15
Brussels 14
New York 14
Ottawa 14
London 13
Munich 13
Warsaw 13
Brooklyn 12
Hebei 12
Hyderabad 12
Chicago 11
Shenyang 11
Taizhou 11
Washington 11
Ho Chi Minh City 10
Saint Petersburg 10
San Jose 10
Seattle 10
Pune 9
San Mateo 9
Zhengzhou 9
Brasília 7
Campinas 7
Hangzhou 7
Hanoi 7
Milan 7
Montreal 7
Norwalk 7
Phoenix 7
Poplar 7
San Francisco 7
Santo André 7
Stockholm 7
Tashkent 7
Amsterdam 6
Atlanta 6
Auburn Hills 6
Baghdad 6
Curitiba 6
Istanbul 6
Leawood 6
Santa Clara 6
Toronto 6
Ardabil 5
Campo Grande 5
Dhaka 5
Johannesburg 5
Mexico City 5
Redondo Beach 5
Riva 5
Taiyuan 5
Tunis 5
Abidjan 4
Boston 4
Córdoba 4
Diadema 4
Divinópolis 4
Fortaleza 4
Fuzhou 4
Goiânia 4
Guarulhos 4
Houston 4
Manchester 4
Monmouth Junction 4
Montevideo 4
Nanchang 4
Ningbo 4
Orem 4
Totale 8.690
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.567
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 243
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 191
Anti-HIV agents: design and discovery of new potent RT inhibitors 134
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 124
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 122
Binding modes of noncompetitive AMPA antagonists: a computational approach 117
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 117
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 113
3-D QSAR MODELS AND DOCKING STUDIES OF REVERSIBLE INHIBITORS OF TYPE A AND B MONOAMINE OXIDASE 111
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 111
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 110
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 109
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 108
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 106
Computational studies of inhibitor resistance in HIV-1 integrase 105
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 104
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 103
Efficient 3D Database screening for novel HIV-1 IN inhibitors 103
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 102
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 100
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 99
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 99
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 96
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 95
Design and Synthesis of NR2B Subtype-Selective Antagonist 94
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 92
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 90
Dynamic pharmacophore model development and testing 90
Design and synthesis of new HIV-1 NNRTIs 90
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 90
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 90
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 90
MD STUDIES OF THE WILD TYPE AND MUTANT HIV-1 INTEGRASE COMPLEXED WITH THE 5CITEP INHIBITOR: MECHANISM FOR INHIBITION AND DRUG RESISTANCE 89
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 89
Tetrahydroisoquinoline derivatives: a new class of non-competitive AMPA receptor antagonists with potential anticonvulsant activity 88
Synthesis of new potential HIV-1 integrase inhibitors 88
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 87
DISCOVERY OF HIV-1 INTEGRASE INHIBITORS BY MOLECULAR MODELING STUDIES 87
New trends in the development of AMPA receptor antagonists 86
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 86
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors 83
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 82
Search for noncompetitive 2-amino-3(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies 81
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 81
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 81
PROPOSED MECHANISM FOR THE HIV-1 IN INHIBITION AND DRUG RESISTANCE BY MOLECULAR DYNAMICS STUDIES 80
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 78
Molecular dynamics studies of the full-length integrase-DNA complex 76
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists 75
Molecular dynamics studies of the HIV-1 integrase 74
Noncompetitive AMPA receptor antagonists and proposed pharmacophore model 74
Discovery of novel HIV-1 integrase inhibitors through computational strategies 73
Pharmacophore-based design of HIV-1 integrase inhibitors 72
Rational design, synthesis and SAR of HIV-1 integrase Inhibitors 72
Tetrahydroisoquinoline a new class of noncompetitive AMPA receptor antagonists as potential anticonvulsant agents 72
Tetrahydroisoquinolin-1-ones as anticonvulsant agents 72
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 72
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 72
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance 72
Design e sintesi di nuovi antagonisti noncompetitivi del recettore AMPA 71
DYNAMIC PHARMACOPHORE MODEL DEVELOPMENT AND TESTING 68
NNRTI TBZ-ANALOGHI: PROGETTAZIONE RAZIONALE, SINTESI E SAR 67
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist 67
Isoquinoline derivatives as noncompetitive AMPA receptor antagonists 66
Discovery of a new class of AMPA receptor antagonists containing a tetrahydroisoquinoline skeleton, 66
Rational design and synthesis of novel NNRTI TBZ analogues 64
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 63
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside riverse transcriptase inhibitors 62
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound 59
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 56
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 52
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 32
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 28
null 28
Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors 27
null 27
null 27
null 25
null 25
null 24
Totale 11.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 68 1 69 1 79 48 130
2021/2022457 5 119 3 10 35 0 42 13 8 1 62 159
2022/20231.321 94 90 65 108 108 157 30 99 493 5 65 7
2023/2024339 26 53 17 46 34 68 8 26 1 29 8 23
2024/20251.226 20 35 49 101 14 44 16 289 321 52 84 201
2025/20266.241 131 1.471 3.216 304 269 850 0 0 0 0 0 0
Totale 11.261